pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Hematology · news · pharmadog
← back to Hematology
News · Hematology
637
stories
6d
Roche cuts muscle-sparing obesity drug after mid-stage disappointment
biospace
7d
FDA Approves First Treatment for MCT8 Deficiency
fda press
7d
White House takes stock of US-based manufacturing for 86 essential drugs
endpoints
7d
‘We’re so close to the tech companies’: Genentech CEO talks Fierce through vision for the future
fiercebiotech
7d
Kodiak skyrockets on positive study data for 2 eye drugs
biopharma dive
8d
Regenerative medicine needs more than stem cells
biospace
8d
6 immunology targets to sustain a mammoth I&I market
biospace
10d
Adicet Bio CAR-T sparks lupus remissions in early trial as ‘new era’ of autoimmune treatment approaches
fiercebiotech
10d
ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public
biospace
10d
Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data
biopharma dive
11d
Angiographic Catheter Recall: Boston Scientific Removes Imager II Angiographic Catheters
fda medwatch
11d
ADARx scores upsized $446M IPO, while fellow RNA biotech City maps out Nasdaq plans
fiercebiotech
11d
RNAi drug specialist ADARx raises $446M IPO
biopharma dive
11d
Grail multicancer detection test wins FDA advisers’ backing
biopharma dive
11d
Galil Importing Corp Recalls Lior Cinnamon Ground Seasoning Due to Elevated Lead Levels
fda recalls
11d
The FDA’s Overton era, and dispatches from Shanghai
stat
11d
Senate finance committee backs Chris Klomp, advancing him to full Senate vote
stat
11d
Merck reveals study success, and possible safety worries, for eye drug hopeful
biopharma dive
11d
Lilly’s latest China drug deal; Immunovant’s setback in lupus
biopharma dive
11d
Merck’s experimental eye drug matches Roche’s VEGF inhibitor but safety concerns emerge
biospace
11d
Eli Lilly’s weekly insulin shot cleared by FDA, setting up another front in Novo rivalry
biospace
11d
Roche inks up to $2B deal with Atavistik for new cardiometabolic drugs
biospace
11d
One of the most contagious diseases on the planet is having its worst U.S. outbreak since 1991
stat
11d
China’s Henlius carves out $440M T-cell engager deal with Amberstone
fiercebiotech
11d
Opinion: Measles almost killed me. Now I’m a doctor — and I’m scared of what’s happening
stat
11d
STAT+: Trump boast on drug pricing policy overstated state-level interest in federal program
stat
11d
Merck sees pivotal victory for $3B eye disease prospect
fiercebiotech
11d
Roche pens backloaded $2B deal with Atavistik to discover allosteric CVRM drugs
fiercebiotech
12d
Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCare
fiercebiotech
12d
Grail survives adcomm vote as it awaits FDA decision for cancer blood test
fiercebiotech
← prev
page 2 of 22
next →
